Science & Enterprise subscription

Follow us on Twitter

  • National Science Foundation is funding a new system that uses artificial intelligence to find optimal combinations… https://t.co/jbZAJqQpmT
    about 21 hours ago
  • New post on Science and Enterprise: NSF Funds AI Covid-19 Drug Combo Simulation https://t.co/j7DsIncCUk #Science #Business
    about 21 hours ago
  • A spin-off enterprise from academic labs is raising $125 million for genetically edited pigs to produce organs for… https://t.co/CVwEr6dEoU
    about 21 hours ago
  • New post on Science and Enterprise: Gene-Edited Transplant Organ Company Raises $125M https://t.co/UYlUcA8Z5X #Science #Business
    about 1 day ago
  • A home Covid-19 test is being evaluated with a smartphone app, as part of an NIH program to quickly develop Covid-1… https://t.co/82gYsU3rvr
    about 2 days ago

Please share Science & Enterprise

NIH Assessing Home Covid-19 Diagnostic with App

QuickVue test package

A home Covid-19 test is being evaluated with a smartphone app, as part of an NIH program to quickly develop Covid-19 diagnostics for widespread use. . . . → Read More: NIH Assessing Home Covid-19 Diagnostic with App

U.S. Supports Home Smartphone Covid-19 Test

Ellume home Covid-19 test

The U.S. government is funding large-scale production of Covid-19 home test kits that send results to the user’s smartphone. . . . → Read More: U.S. Supports Home Smartphone Covid-19 Test

Antibody Therapy Shown to Prevent Covid-19 Disease

Global Covid-19

Clinical trial results show a combination of synthetic antibodies designed to treat Covid-19 infections can also prevent contracting the disease. . . . → Read More: Antibody Therapy Shown to Prevent Covid-19 Disease

Covid-19 Vaccine Shown Active Against Variants

Syringes

Moderna Inc., developer of a vaccine to prevent Covid-19 disease, says lab test results show antibodies from the vaccine neutralize two recently found viral mutations. . . . → Read More: Covid-19 Vaccine Shown Active Against Variants

U.S. Rejoins WHO, Participates in Int’l Vaccine Project

White House

In one of its first actions, the Biden administration rejoined the United States in the World Health Organization, reversing a policy of its predecessor. . . . → Read More: U.S. Rejoins WHO, Participates in Int’l Vaccine Project

Antibodies Prevent Covid-19 Symptoms in Long-Term Care

Mobile lab team

A clinical trial shows long-term care residents and staff receiving a synthetic antibody treatment have a lower risk of getting symptomatic Covid-19 infections. . . . → Read More: Antibodies Prevent Covid-19 Symptoms in Long-Term Care

Multi-Variant Covid-19 Vaccine in the Works

SARS-CoV-2 and cell

A vaccine protecting against multiple Covid-19 viral variations is in development, with an early-stage clinical trial expected to begin soon. . . . → Read More: Multi-Variant Covid-19 Vaccine in the Works

Moderna Developing Flu, HIV, Nipah Vaccines

Syringe and three vials

Moderna Inc., developer of a currently authorized Covid-19 vaccine, is expanding its vaccine pipeline to cover three more common infectious viral diseases. . . . → Read More: Moderna Developing Flu, HIV, Nipah Vaccines

Small Biz Grant Funds Heat-Stable Multi-Virus Vaccine

SARS-Cov-2 viruses

A biotechnology company is receiving a federal grant for a vaccine in freeze-dried form to prevent infections from Covid-19 and Ebola viruses. . . . → Read More: Small Biz Grant Funds Heat-Stable Multi-Virus Vaccine

Large Trial Testing Covid-19 Antibody Therapies

Global Covid-19

A clinical trial conducted by National Institutes of Health is evaluating two more synthetic antibodies as treatments for patients hospitalized with Covid-19 infections. . . . → Read More: Large Trial Testing Covid-19 Antibody Therapies